AGRX

Agile Therapeutics
AGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

29 hedge funds and large institutions have $5.32M invested in Agile Therapeutics in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$180K
2
+$158K
3
+$26.6K
4
Citadel Advisors
Citadel Advisors
Florida
+$24K
5
VF
Virtu Financial
New York
+$23.8K

Top Sellers

1
-$1.74M
2
-$302K
3
-$60K
4
Deutsche Bank
Deutsche Bank
Germany
-$55K
5
WS
Wedbush Securities
California
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4K
27
$1K
28
$192
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
1
2